Rezolute (RZLT) Amortizatization of Intangibles (2012 - 2026)
Rezolute (RZLT) posted Amortizatization of Intangibles of $481000.0 for Q1 2026, down 32.54% sequentially from $713000.0 in Q4 2025, and down 4.18% YoY from $502000.0 in Q1 2025.
Powered by 
Analysis
Rezolute (RZLT) Amortizatization of Intangibles (2012 - 2026) Analysis & Trends
Rezolute has reported Amortizatization of Intangibles for 9 years, with the latest figure at $481000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 4.18% year-over-year to $481000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 16.74% YoY) and the FY2025 annual result came in at $2.4 million, down 15.62% from the prior year.
- Amortizatization of Intangibles slipped to $481000.0 in Q1 2026 per RZLT's latest filing, from $713000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $2.2 million in Q4 2023 and troughed at -$973000.0 in Q3 2023.
- A 4-year average of $657166.7 and a median of $718000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 185.71% in 2024, down 66.43% in 2024.
- Over 4 years, Amortizatization of Intangibles stood at $2.2 million in 2023, then tumbled by 66.43% to $723000.0 in 2024, then decreased by 1.38% to $713000.0 in 2025, then sank by 32.54% to $481000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $481000.0, $713000.0, and $799000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | 481,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 481,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 799,000.00 |
| Jun 30, 2025 | 335,000.00 |
| Mar 31, 2025 | 502,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 737,000.00 |
| Mar 31, 2024 | 919,000.00 |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | -973,000.00 |
| Jun 30, 2023 | 662,000.00 |
| Dec 31, 2018 | 878,542.00 |
| Sep 30, 2018 | 702,621.00 |
| Jun 30, 2018 | 473,768.00 |
| Mar 31, 2018 | 31,697.00 |
| Mar 31, 2014 | 2.94 Mn |
| Dec 31, 2013 | 417,636.00 |
| Mar 31, 2013 | 2,283.00 |
| Dec 31, 2012 | 6,450.00 |